Search

Search Results
Results 851 - 860 of 1629 for multiple myeloma
  • News - 13 Apr 2008
    Preliminary data from one of the first clinical trials to test a stem cell-targeting drug in cancer patients shows that while the drug did not prolong survival, its suppressing effect on patients'...
  • News - 9 Mar 2006
    Myeloma is one of the least curable cancers and involves plasma cells, the white blood cells that produce antibodies.
  • News - 25 May 2026
    The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick...
  • Life Sciences - 28 Nov 2025
    Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision medicine and drug discovery.
  • Health - 31 Dec 2022
    Amyloidosis is caused by the accumulation of misfolded proteins in tissues and organs of the body. There are three main types of amyloidosis, each of which have different underlying pathologies.
  • Drug - 1 Jul 2026
    Consumer Medicine Information (CMI) about Darzalex intended for persons living in Australia.
  • Drug - 20 Apr 2026
    Consumer Medicine Information (CMI) about Darzalex SC intended for persons living in Australia.
  • Drug - 13 Feb 2026
    Consumer Medicine Information (CMI) about Blenrep intended for persons living in Australia.
  • News - 17 Sep 2025
    The American Association for Cancer Research (AACR) released the 15th edition of its annual Cancer Progress Report. A cornerstone of the AACR's educational and advocacy efforts, this comprehensive...
  • News - 11 May 2025
    New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal eClinicalMedicine finds that first generation weight-loss...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.